106 results
DEFA14A
RYTM
Rhythm Pharmaceuticals Inc.
26 Apr 24
Additional proxy soliciting materials
4:10pm
of the named executive officers of the Company. 4. Reapproval of the Rhythm Pharmaceuticals, Inc. 2017 Equity Incentive Plan. PLEASE NOTE – YOU CANNOT VOTE
8-K
EX-10.1
RYTM
Rhythm Pharmaceuticals Inc.
1 Apr 24
Rhythm Pharmaceuticals Secures $150 Million in Convertible Preferred Stock Financing
5:25pm
and outstanding, (ii) 11,908,984 shares of Common Stock were reserved for issuance under the Company’s equity incentive plans including (x) 2,565,331 shares
S-8
EX-5.1
RYTM
Rhythm Pharmaceuticals Inc.
29 Feb 24
Registration of securities for employees
4:58pm
to the Rhythm Pharmaceuticals, Inc. 2017 Equity Incentive Plan (the “2017 Plan”). This opinion is being furnished in connection with the requirements
S-8
RYTM
Rhythm Pharmaceuticals Inc.
29 Feb 24
Registration of securities for employees
4:58pm
Offering Price
Per Unit
Maximum
Aggregate Offering
Price
Fee Rate
Amount of
Registration Fee
2017 Incentive Award Plan
Equity
Common Stock, par value … securities that may from time to time be offered or issued under the Rhythm Pharmaceuticals, Inc. 2017 Incentive Award Plan (the “Incentive Plan”) to prevent
S-8
xd467c g6gd2ykguc
29 Feb 24
Registration of securities for employees
4:58pm
S-8
EX-23.1
fnurbtzf05 1owsods
29 Feb 24
Registration of securities for employees
4:58pm
424B5
aejkds4t
29 Feb 24
Prospectus supplement for primary offering
4:44pm
8-K
EX-10.1
2iccgs515 s44mfc
3 Aug 23
Departure of Directors or Certain Officers
5:22pm
8-K
EX-10.2
y2vu7xhjx9
3 Aug 23
Departure of Directors or Certain Officers
5:22pm
8-K
EX-10.4
npgvub
3 Aug 23
Departure of Directors or Certain Officers
5:22pm
8-K
EX-10.3
y7uz9
3 Aug 23
Departure of Directors or Certain Officers
5:22pm